These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 24261365

  • 1. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
    Wehrli NE, Kim MJ, Matza BW, Melamed J, Taneja SS, Rosenkrantz AB.
    AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
    [Abstract] [Full Text] [Related]

  • 2. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results.
    Rosenkrantz AB, Haghighi M, Horn J, Naik M, Hardie AD, Somberg MB, Melamed J, Xiao GQ, Huang WC, Taouli B.
    AJR Am J Roentgenol; 2013 Dec; 201(6):1254-9. PubMed ID: 24261364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Preoperative T categorization and prediction of histopathologic grading of urothelial carcinoma in renal pelvis using diffusion-weighted MRI.
    Akita H, Jinzaki M, Kikuchi E, Sugiura H, Akita A, Mikami S, Kuribayashi S.
    AJR Am J Roentgenol; 2011 Nov; 197(5):1130-6. PubMed ID: 22021505
    [Abstract] [Full Text] [Related]

  • 6. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI.
    Choi YA, Kim CK, Park SY, Cho SW, Park BK.
    AJR Am J Roentgenol; 2014 Jul; 203(1):W78-84. PubMed ID: 24951231
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
    Rosenkrantz AB, Wehrli NE, Melamed J, Taneja SS, Shaikh MB.
    Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
    [Abstract] [Full Text] [Related]

  • 9. Investigation of renal lesions by diffusion-weighted magnetic resonance imaging applying intravoxel incoherent motion-derived parameters--initial experience.
    Rheinheimer S, Stieltjes B, Schneider F, Simon D, Pahernik S, Kauczor HU, Hallscheidt P.
    Eur J Radiol; 2012 Mar; 81(3):e310-6. PubMed ID: 22104090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma.
    Wang HJ, Pui MH, Guo Y, Li SR, Guan J, Zhang XL, Cai HS.
    AJR Am J Roentgenol; 2015 Feb; 204(2):330-4. PubMed ID: 25615755
    [Abstract] [Full Text] [Related]

  • 13. Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas.
    Cornelis F, Lasserre AS, Tourdias T, Deminière C, Ferrière JM, Le Bras Y, Grenier N.
    AJR Am J Roentgenol; 2013 Apr; 200(4):830-8. PubMed ID: 23521457
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G, Koc Z, Karadeli E, Kuzgunbay B, Goren MR, Bal N.
    Acta Radiol; 2012 Apr 01; 53(3):359-65. PubMed ID: 22334870
    [Abstract] [Full Text] [Related]

  • 15. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.
    Maruyama M, Yoshizako T, Uchida K, Araki H, Tamaki Y, Ishikawa N, Shiina H, Kitagaki H.
    Acta Radiol; 2015 Feb 01; 56(2):250-6. PubMed ID: 24518687
    [Abstract] [Full Text] [Related]

  • 16. Pseudotumours in chronic kidney disease: can diffusion-weighted MRI rule out malignancy.
    Goyal A, Sharma R, Bhalla AS, Gamanagatti S, Seth A.
    Eur J Radiol; 2013 Nov 01; 82(11):1870-6. PubMed ID: 23932396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y, Liu Q.
    J Comput Assist Tomogr; 2012 Nov 01; 36(4):361-6. PubMed ID: 22805661
    [Abstract] [Full Text] [Related]

  • 20. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS.
    AJR Am J Roentgenol; 2010 Dec 01; 195(6):W421-7. PubMed ID: 21098174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.